NATALIA SAUNDERS-ROBERTS: Open Payments
NPI 1063858249 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 31 payments from 9 companies in 2025. Trend: 2023 $36 · 2024 $501 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $249 |
| Teva Pharmaceuticals USA, Inc. | 6 | $193 |
| Alkermes, Inc. | 10 | $186 |
| Collegium Pharmaceutical, Inc. | 2 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Braeburn Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: COBENFY, UZEDY, ARISTADA, Jornay PM, CAPLYTA, INVEGA SUSTENNA, FANAPT, BRIXADI.
Industry payments across FL — which companies pay providers there.
